GlaxoSmithKline PLC (NYSE:GSK)

36.65
BATS BZX Real-Time Price
As of 10:25am ET
 +0.0885 / +0.24%
Today’s Change
34.52
Today|||52-Week Range
44.54
+3.33%
Year-to-Date
GSK Regular Dividend: GSK will begin trading ex-dividend today with a $0.6385 dividend payable to shareholders of record as of 02/23/18.
Top Stock Reports for Walmart, Cisco, Intel & UPS
Feb 21 / Zacks.com - Paid Partner Content
Glaxo's (GSK) Begins Phase III HIV Two-Drug Regimen Study
Feb 09 / Zacks.com - Paid Partner Content
Ionis Out-Licenses Second Candidate to AstraZeneca, Earns $30M
Feb 21 / Zacks.com - Paid Partner Content
Glaxo (GSK) Earnings and Revenues Surpass Estimates in Q4
Feb 08 / Zacks.com - Paid Partner Content
Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
Feb 16 / TheStreet.com - Paid Partner Content
FDA Approves Gilead (GILD) HIV Triple Therapy, Stock Up
Feb 08 / Zacks.com - Paid Partner Content
Foreign Stock Roundup: TOT, STO & GSK Earnings Impress, BP & SNY Disappoint
Feb 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close36.56
Today’s open36.63
Day’s range36.59 - 36.71
Volume79,841
Average volume (3 months)5,394,294
Market cap$92.2B
Data as of 10:25am ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+59.84%
Earnings growth (this year)-2.02%
Earnings growth (next 5 years)+3.93%
Revenue growth (last year)+3.58%
P/E ratio27.8
Price/Sales2.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.28-0.42%
NVONovo Nordisk+1.70+3.30%
CELGCelgene+1.09+1.16%
ABTAbbott Laboratories+0.10+0.17%
Data as of 10:25am ET, 02/22/2018

Financials

Next reporting dateApril 25, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$38.9B
Annual profit (last year)$2.0B
Net profit margin5.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts